16. Japanese Encephalitis Vaccine |
PROPER NAME |
COMMERCIAL NAME (click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS (not in order of quantity; see package insert for quantities) |
Japanese Encephalitis Vaccine, Inactivated, Adsorbed |
Ixiaro |
|
Intercell Biomedical |
Sep. 2010 |
|
Vero cells, protamine sulfate, formaldehyde, aluminum hydroxide |
aluminum hydroxide, formaldehyde, bovine serum albumin, host cell DNA, sodium metabisulphate, host cell proteins, protamine sulphate |
Japanese Encephalitis Vaccine, Inactivated |
JE-Vax |
|
Research Foundation for Microbial Diseases of Osaka University |
Dec. 2005 |
|
mice (brains are innoculated with the virus), phosphate-buffered saline, formaldehyde, 40% w/v sucrose |
thimerosal, Sterile Water for Injection, gelatin, formaldehyde, v/v Polysorbate 80, mouse serum protein |
|
17. Measles Vaccine |
PROPER NAME |
COMMERCIAL NAME (click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS (not in order of quantity; see package insert for quantities) |
|
Merck &Co., Inc. |
Feb. 2006 |
|
chick embryo cell culture, buffered salt solution, vitamins, amino acides, fetal bovine serum, SPGA (sucrose, phosphate, gluatamate, human albumin), neomycin |
sorbitol, sodium phosphate, sucrose, sodium, chloride, hydrolyzed gelatin, human albumin, fetal bovine serum, neomycin, other buffer and media ingredients |
|
18. Meningococcal Vaccine (meningitis) |
PROPER NAME |
COMMERCIAL NAME (click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS (not in order of quantity; see package insert for quantities) |
Meningococcal Polysaccharide (Serogroups A, C, Y and W-135) Diphtheria Toxoid Conjugate Vaccine |
MCV4-Menactra |
|
Sanofi Pasteur Inc. |
Nov. 2011 |
|
Mueller Hinton agar, Watson Scherp media, Mueller and Miller medium, formaldehyde, ammonium sulfate |
formaldehyde, sodium phosphate buffered isotonic sodium chloride solution, |
Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine |
MenHibrix |
|
GlaxoSmithKline Biologicals |
2012 |
|
synthetic medium, formaldehyde, sucrose, saline diluent |
Tris (trometamol)-HCL, sucrose, residual formaldehyde |
Meningococcal (Groups A, C, Y, and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine |
Menveo |
|
Novartis Vaccines and Diagnostics, Inc. |
Mar. 2011 |
|
Franz Complete medium, formaldehyde, CY medium (contains yeast extracts and amino acids), |
formaldehyde |
|
Sanofi Pasteur Inc. |
Jan. 2009 |
|
Mueller Hinton casein agar, Watson Scherp casamino acid media |
distilled water, thimersol, polysaccharide from serogroups A, C, Y, and w-135, mercury, lactose |
|
19. MMR Vaccine (measles, mumps, & rubella) |
PROPER NAME |
COMMERCIAL NAME (click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS (not in order of quantity; see package insert for quantities) |
Measles, Mumps, and Rubella Virus Vaccine, Live |
M-M-R-II |
|
Merck and Co., Inc. |
Dec. 2010 |
|
chick embryo cell culture, WI-38 human diploid lung fibroblasts, Medium 199 (containing vitamins, amino acids, fetal bovine serum, SPGA (sucrose, phosphate, glutamate, recomninant human albumin), neomycin), Minimum Essential Medium (containing vitamins, amino acids, fetal bovine serum, recombinant human albumin, neomycin), sorbitol, hydrolyzed gelatin stabilizer |
sorbitol, sodium phosphate, sucrose, sodium chloride, hydrolyzed gelatin, recombinant human albumin, fetal bovine serum, other buffer and media ingredients, neomycin |
|
Merck and Co., Inc. |
Aug. 2011 |
|
chick embryo cell culture, WI-38 human diploid lung fibroblasts, MRC-5 cells, bovine serum, human albumin |
sucrose, hydrolized gelatin, urea, sodium chloride, sorbitol, monodium L-glutamate, sodium phosphate, human albumin, sodium bicarbonate, potassium phosphate, potassium chloride, residual components of MRC-5 cells (including DNA and protein), neomycin, bovine serum albumin, other buffer and media ingredients, sodium phosphate dibasic, potassium phosphate monobasic, potassium phosphate dibasic |
|
20. Pneumococcal Vaccine (pneumonia) |
PROPER NAME |
COMMERCIAL NAME (click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS (not in order of quantity; see package insert for quantities) |
Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein) |
Prevnar |
|
Wyeth Pharmaceuticals Inc. |
Mar. 2009 |
|
soy peptone broth, casamino acids and yeast extract-based medium, ammonium sulfate, saccharides |
aluminum (as aluminum phosphate adjuvant) |
Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein) |
Prevnar 13 |
|
Wyeth Pharmaceuticals Inc. |
Jan. 2012 |
|
soy peptone broth, casamino acids and yeast extract-based medium, ammonium sulfate |
polysorbate 80, succinate buffer, aluminum (as aluminum phosphate adjuvant) |
|
Merck & Co., Inc. |
Oct. 2011 |
|
-- |
isotonic saline solution, phenol |
|
21. Polio Vaccine |
PROPER NAME |
COMMERCIAL NAME (click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS (not in order of quantity; see package insert for quantities) |
Poliovirus Vaccine Inactivated (Monkey Kidney Cell) |
IPOL |
|
Sanofi Pasteur, SA |
Dec. 2005 |
|
Vero cells, Eagle MEM modified medium, newborn calf serum, M-199 (without calf serum) |
2-phenoxyethanol, formaldehyde, neomycin, streptomycin, polymyxin B, residual calf serum |
|
22. Rabies Vaccine |
PROPER NAME |
COMMERCIAL NAME (click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS (not in order of quantity; see package insert for quantities) |
|
Sanofi Pasteur, SA |
Dec. 2005 |
|
MRC-5 cells, beta-propiolactone |
human albumin, neomycin sulfate, phenol red indicator, beta-propiolactone |
|
Novartis Vaccines and Diagnostics |
Oct. 2006 |
|
chicken fibroblasts, synthetic cell culture medium, human albumin, polygeline (processed bovine gelatin), antibiotics, B-propiolactone, sucrose density-gradient, buffered polygeline, potassium glutamate |
polygeline (processed bovine gelatin), human serum albumin, potassium glutamate, sodium EDTA, bovine serum, chicken protein, neomycin, chlortracycline, amphotericin B, Water for Injection |
|
23. Rotavirus Vaccine |
PROPER NAME |
COMMERCIAL NAME (click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS (not in order of quantity; see package insert for quantities) |
Rotavirus Vaccine, Live, Oral, Pentavalent |
RotaTeq |
|
Merck & Co., Inc. |
Sep. 2011 |
|
Vero cells, buffered stabilizer, porcine-derived materials |
sucrose, sodium citrate, sodium phosphate monobasic monohydrate, sodium hydroxide, polysorbate 80, cell culture media, fetal bovine serum (trace), DNA for porcine circoviruses |
Rotavirus Vaccine, Live, Oral |
Rotarix |
|
GlaxoSmithKline Biologicals |
Feb. 2011 |
|
Vero cells, porcine-derived materials |
amino acids, dextran, Dulbecco's Modified Eagle Medium (sodium chloride, potassium chloride, magnesium sulfate, ferric (III) nitrate, sodium phosphate, sodium pyruvate, D-glucose, concentrated vitamin solution, L-cystine, L-tyrosine, amino acids solution, L-glutamine, calcium chloride, sodium hydrogenocarbonate, phenol red), sorbitol, sucrose, calcium carbonate, sterile water, xanthan |
|
24. Rubella Vaccine |
PROPER NAME |
COMMERCIAL NAME (click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS (not in order of quantity; see package insert for quantities) |
|
Merck & Co., Inc. |
Feb. 2006 |
|
WI-38 human diploid lung fibroblasts, Minimum Essential Medium (MEM; buffered salt solution (vitamins, amino acids, bovine serum), human serum albumin, neomycin), sorbitol, hydrolyzed gelatin stabilizer |
sorbitol, sodium phosphate, sucrose, sodium chloride, hydrolyzed gelatin, human albumin, fetal bovine serum, other buffer and media ingredients, neomycin |
|
25. Smallpox Vaccine |
PROPER NAME |
COMMERCIAL NAME (click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS (not in order of quantity; see package insert for quantities) |
Smallpox (Vaccinia) Vaccine, Live |
ACAM2000 |
|
Sanofi Pasteur Biologics Co. |
Aug. 2007 |
|
Vero cells, human serum albumin, sodium chloride, mannitol USP, meomycin, polymyxin B |
glycerin USP, phenol USP in Water for Injection USP |
|
26. TD Vaccine (tetanus & diphtheria) |
PROPER NAME |
COMMERCIAL NAME (click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS (not in order of quantity; see package insert for quantities) |
Tetanus and Diphtheria Toxoids Adsorbed For Adult Use |
DECAVAC |
|
Sanofi Pasteur, Inc. |
Mar. 2011 |
|
Mueller and Miller medium, peptone-based medium, extract of bovine muscle tissue, formaldehyde, ammonium sulfate |
thimerosal, aluminum potassium sulfate adjuvant, residual formaldehyde |
Tetanus and Diphtheria Toxoids Adsorbed For Adult Use |
TENIVAC |
|
Sanofi Pasteur, Ltd. |
Dec. 2010 |
|
modified Mueller-Miller casamino acid medium without beef heart infusion, formaldehyde, ammonium sulfate, modified Mueller's growth medium, aluminum phosphate, 2-phenoxyethanol, sodium chloride |
aluminum phosphate, residual formaldehyde, 2-phenoxyethanol, sodium chloride, water for injection |
Tetanus and Diphtheria Toxoids, Adsorbed |
-- |
|
|
modified Mueller's media (contains bovine extracts), formaldehyde, ammonium sulfate, aluminum phosphate |
aluminum adjuvant, residual formaldehyde, thimerosal |
|
Sanofi Pasteur, Inc. |
Dec. 2005 |
|
peptone-based medium, formaldehyde, ammonium sulfate, physiological saline solution |
thimerosal, formaldehyde |
Tetanus Toxoid Absorbed |
-- |
|
Sanofi Pasteur, Inc. |
July 2005 |
|
peptone-based medium (contains extract of bovine muscle tissue), formaldehyde, ammonium sulfate, aluminum potassium sulfate (alum) |
thimerosal, physiological saline solution |
|
27. Tdap Vaccine (tetanus, diphtheria, & pertussis) |
PROPER NAME |
COMMERCIAL NAME (click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS (not in order of quantity; see package insert for quantities) |
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed |
Adacel |
|
Sanofi Pasteur, Ltd. |
Dec. 2010 |
|
Stainer-Scholte medium, casamino acids, dimethyl-beta-cyclodextrin, glutaraldehyde, formaldehyde, aluminum phosphate, modified Mueller-Miller casamino acid medium without beef heart infusion, ammonium sulfate, 2-phenoxyethanol, water for injection |
aluminum phosphate, residual formaldehyde, residual glutaraldehyde, 2-phenoxyethanol |
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed |
Boostrix |
|
GlaxoSmithKline Biologicals |
Jan. 2012 |
|
modified Latham medium derived from bovine casein, Fenton medium containing bovine extract, formaldehyde, Stainer-Scholte liquid medium, glutaraldehyde, aluminum hydroxide |
aluminum hydroxide, sodium chloride, residual formaldehyde, polysorbate 80 (Tween 80) |
|
28. Typhoid Vaccine |
PROPER NAME |
COMMERCIAL NAME (click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS (not in order of quantity; see package insert for quantities) |
|
Sanofi Pasteur SA |
Dec. 2005 |
|
semi-synthetic medium without animal proteins, hexadecyltrimethylammonium bromide |
residual polydimethylsoloxane or fatty-acid ester-cased antifoam, isotonic phosphate buffered saline, sodium chloride, disodium phosphate, monosodium phosphate, sterile water for injection |
Typhoid Vaccine Live Oral Ty21a |
Vivotif |
|
Berna Biotech, Ltd. |
Aug. 2006 |
|
yeast extract, casein, dextrose, and galactose, sucrose, ascorbic acid, amino acids, lactose, magnesium stearate |
sucrose, ascorbic acid, amino acid mixture, lactose, magnesium stearate |
|
29. Varicella Vaccine (chickenpox) |
PROPER NAME |
COMMERCIAL NAME (click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS (not in order of quantity; see package insert for quantities) |
|
Merck & Co., Inc. |
Aug. 2011 |
|
human embryonic lung cell cultures, embryonic guinea pig cell cultures, WI-38 human diploid cell cultures, MRC-5 human diploid cell cultures, sucrose, phosphate, glutamate, processed gelatin, urea |
sucrose, hydrolyzed gelatin, urea, sodium chloride, monosodium L-glutamate, sodium phosphate dibasic, potassium phosphate monobasic, potassium chloride, residual components of MRC-5 cells (DNA, protein), neomycin, bovine calf serum, sodium phosphate monobasic, EDTA, fetal bovine serum |
|
30. Yellow Fever Vaccine |
PROPER NAME |
COMMERCIAL NAME (click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS (not in order of quantity; see package insert for quantities) |
|
Sanofi Pasteur, Inc. |
Jan. 2010 |
|
living avian leukosis virus-free (ALV-free) chicken embryos |
sorbitol, gelatin |
|
31. Zoster Vaccine (shingles) |
PROPER NAME |
COMMERCIAL NAME (click for package insert) |
|
MANUFACTURER |
PACKAGE INSERT DATE |
|
GROWTH MEDIUMS & PROCESS INGREDIENTS |
VACCINE INGREDIENTS (not in order of quantity; see package insert for quantities) |
|
Merck & Co., Inc. |
June 2011 |
|
-- |
sucrose, hydrolyzed porcine gelatin, sodium chloride, monosodium L-glutamate, sodium phosphate dibasic, potassium phosphate monobasic, potassium chloride, residual components of MRC-5 cells (DNA, protein), neomycin, bovine calf serum |
Kommentera